| Literature DB >> 35406337 |
Laura S Pires1, Fernão D Magalhães1, Artur M Pinto1,2,3.
Abstract
The constant evolution and advancement of the biomedical field requires robust and innovative research. Two-dimensional nanomaterials are an emerging class of materials that have risen the attention of the scientific community. Their unique properties, such as high surface-to-volume ratio, easy functionalization, photothermal conversion, among others, make them highly versatile for a plethora of applications ranging from energy storage, optoelectronics, to biomedical applications. Recent works have proven the efficiency of 2D nanomaterials for cancer photothermal therapy (PTT), drug delivery, tissue engineering, and biosensing. Combining these materials with hydrogels and scaffolds can enhance their biocompatibility and improve treatment for a variety of diseases/injuries. However, given that the use of two-dimensional nanomaterials-based polymeric composites for biomedical applications is a very recent subject, there is a lot of scattered information. Hence, this review gathers the most recent works employing these polymeric composites for biomedical applications, providing the reader with a general overview of their potential.Entities:
Keywords: MXenes; antibacterial; antimicrobial; biosensing; black phosphorus; cancer phototherapy; drug delivery; hydrogels; scaffolds; tissue regeneration; transition metal dichalcogenides
Year: 2022 PMID: 35406337 PMCID: PMC9003422 DOI: 10.3390/polym14071464
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1Summary of new 2D nanomaterials beyond graphene. These include transition metal dichalcogenides (TMDs); transition metal oxides (TMOs); hexagonal boron nitride (hBN); transition metal carbides, nitrides and carbonitrides (MXenes); black phosphorus (BP); layered double hydroxides (LDHs); nanoclay; 2D metal-organic frameworks (MOFs).
Figure 2Overview of the biomedical applications of two-dimensional nanomaterials (2DnMat). 2DnMat can be used, for example, for photothermal therapy induced by near infrared (NIR) radiation; photodynamic therapy (PDT), combining light irradiation with photosensitizer drugs; for diagnostic imaging, such as photoluminescent, photoacoustic, magnetic resonance (MR) or computed tomography (CT) imaging; for antimicrobial effect through direct membrane damages or production of reactive oxygen species (ROS). Additionally,2D nanomaterials can be designed to present low cytotoxicity and adequate biosafety. They can also be used to develop innovative biosensors. Adapted from [33] © 2018 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Two-dimensional nanomaterials-based polymeric composites for biomedical applications, their specific functions, and general outcomes (↑ : increase; ↓ : decrease).
| 2DnMat | Composite | Composite Preparation | Application | Outcomes | Ref. |
|---|---|---|---|---|---|
| BP | PVA/pBP Hydrogel | pBP solution added to PVA solution followed by the freezing/thawing method. | NIR-Responsive Drug Release | ↑ mechanical properties | [ |
| PLEL/BP Hydrogel | BP nanosheets were dispersed in a PLEL solution by sonication. | Sprayable Gel for PTT | No cytotoxic effects observed for hMSCs, L929 and HeLa cells. | [ | |
| Cellulose/BP Hydrogel | Celullose, BP, and epichlorohydrin solutions were mixed. The solution was cross-linked. Dialysis was performed to removed excess reagents. | PTT | ↑ mechanical properties with ↑ BP% | [ | |
| Agarose/BP@PEG Hydrogel, loaded with DOX | BP@PEG nanosheets, agarose aqueous solution and DOX were mixed and rapidly cooled. | Drug Delivery Induced by PTT | No cytotoxic effects observed for MDA-MB-231, A549, HeLa and B16 cells | [ | |
| BP/PEA/GelMA Hydrogel | A GelMA and PEA solution was submitted to photopolymerization. BP nanosheets were added to the hydrogel, followed by UV irradiation. | Bone Regeneration | ↑ water-absorption capacity | [ | |
| Fibrin/BP Gel | Fibrinogen solutions with BP nanosheets were mixed with thrombin through spraying. | Diabetic Ulcer Treatment + Analgesic + Antibacterial PTT | ↑ gelation time with ↑ BP% | [ | |
| BG/BP 3D-printed Scaffold | BG scaffolds were 3D-printed and subsequently soaked in a BP absolute ethyl alcohol solution. | PTT + Bone Regeneration | ↑ proliferation of Saos-2 cells | [ | |
| GelMA/BP@PDA Hydrogel | BP@PDA and GelMA solutions were sonicated until homogeneous, followed by UV irradiation. | MSCs Differentiation | ↑ BP@PDA ↓ the swelling ratio of the hydrogel | [ | |
| BP/PCL Nanoscaffold | BP nanoplates were incorporated in a PCL dicloromethane solution. The solution was sprayed onto a conduit shaped mold. | Neural Regeneration | ↑ electrical conductivity with ↑ %BP | [ | |
| MoS2 | PLGA/MoS2@PEG/DOX Injectable Implant | PLGA was dispersed in NMP, MoS2 was dispersed in the PLGA/NMP solution and DOX was dissolved in the PLGA/MoS2 dispersion. | Drug Delivery + PTT | No cytotoxic effects were observed for L929 cells. | [ |
| PAN/MoS2 Nanofibers | PAN was added to a MoS2/N,N-dimethylformamide solution and electrospun. | Composite Effects on BMSCs | ↑ %MoS2 ↑ nanofiber surface roughness | [ | |
| Ti3C2Tx | PLA/Ti3C2Tx@OTES Membrane | Solvent casting was used to embed Ti3C2Tx@OTES in PLA. | Bone Regeneration | ↑ mechanical properties of the membrane are increased prior to saturation of the filler | [ |
| PNIPAM/Ti3C2Tx Hydrogel | PNIPAM and a cross-linker were added to a Ti3C2Tx solution and purged, followed by the addition of a polymerization accelerator. | PTT | MXene did not disrupt the hydrogel network | [ | |
| PLA/Ti3C2Tx Nanofibers | Electrospun PLA was immersed in a Ti3C2Tx solution. | Antibacterial | ↑ roughness of the nanofibers | [ | |
| Chitosan/Ti3C2Tx Nanofibers | Ti3C2Tx was loaded onto a chitosan solution and electrospun. | Antibacterial Wound Dressing | Stable electrospinning | [ | |
| F127-PEI-OSA/Ti3C2Tx@CeO2 Hydrogel | A solution of F127-PEI, OSA, and Ti3C2Tx@CeO2 was prepared was kept at 37 °C. | Multifunctional Wound Healing Scaffold | No cytotoxic effects were observed with L929 cells | [ | |
| PGE/HCHO/Ti3C2Tx@PDA Scaffold | Ti3C2Tx@PDA and PEG solutions were mixed in a HCHO solution and vortexed until homogenous. | Multifunctional Antibacterial Wound Healing | L929 cells adhered to the scaffolds | [ | |
| PAAm-PVA/Ti3C2Tx Hydrogel | The individual components that comprise the hydrogel were mixed in a aqueous solution with an initiator, followed by the addition of borax until a gel is formed. | Biosensor | ↑ hydrogel conductivity | [ | |
| PVA/Ti3C2Tx Hydrogel | A Ti3C2Tx solution was mixed with a PVA solution, followed by the addition of borax. | Biosensor, Electronic skin | ↑ hydrogel stretchability | [ | |
| PVDF-TrFE/Ti3C2Tx Nanofibers | Ti3C2Tx was added to a PVDF-TrFE solution and electrospun. | Biosensor for Physiological Signal Acquisition | The sensor showed good capabilities in recognizing pulse signals in the wrist, breathing, and promising results for future aiding of Parkinson’s diagnose by measuring unnoticeable resting tremor in hands | [ | |
| Ti3C2 | Ti3C2/Honey/Chitosan Hydrogel | Ti3C2 was added to a chitosan hydrogel solution, followed by the addition of honey, β-glycerophosphate and hydroxyethyl cellulose. | Biomedical Applications | Good swelling ability, biodegradable, and self-healing | [ |
| BG/Ti3C2 3D-Printed Scaffolds | 3D-printed scaffolds were soaked in Ti3C2 aqueous solution. | PTT + Bone Regeneration | No cytotoxic effects were observed for Saos-2 cells | [ | |
| PCL/Ti3C2 Electrospun Scaffolds | PCL was added to Ti3C2 was dispersed on a dimethylformamide and chloroform solution and electrospun. | Biomedical Applications—study | ↑ fiber diameter with ↑ MXene content | [ | |
| Cellulose/Ti3C2 Hydrogel | The same method as described in [ | PTT + Drug Release | No cytotoxic effects were observed for HepAl-6, SMMC-7721, HepG2, U-118MG and U-251MG cells. | [ | |
| PAM/Ti3C2 Hydrogel | The hydrogel was prepared using a free radical polymerization method. An aqueous Ti3C2 solution was mixed with acrylamide and an initiator to initiate polymerization. | Drug Release | ↑ mechanical properties of the hydrogel | [ | |
| PLLA-PHA/Ti3C2 Nanofibers | PLLA and PHA were added to a Ti3C2 dichloromethane/dimethylformamide solution. | Tissue Engineering | ↑ adhesion and slightly ↑ proliferation of BMSCs | [ | |
| PAN-PVP/Ti3C2@PAAV Fibrous Nanobelts | PAN and PVP were added to a Ti3C2 dimethylformamide solution and electrospun. The nanofibers were soaked in a PAAV aqueous solution. | Wound Healing + Drug delivery | ↑ adhesion and ↑ proliferation of BMSCs | [ | |
| PVA/AMX/Ti3C2 Nanofibrous Membrane | PVA was dissolved in a Ti3C2 aqueous solution, followed by the addition of AMX. The final solution was electrospun. | Wound Healing + Drug Delivery | No cytotoxic effects were observed for L929 cells | [ | |
| Nb2C | BG/Nb2C@Silica 3D-printed Scaffold | A mesoporous silica layer was coated onto Nb2C nanosheets. 3D-printed BG scaffolds were soaked on a Nb2C@Silica solution. | Bone Regeneration | ↑ NO release is with NIR radiation, maintaining a slow-release profile after | [ |
| SiP | GelMA-PEGDA/SiP@AC 3D-printed Hydrogel | GelMA, PEGDA, and SiP@AC were mixed in a phosphate-buffered saline solution and 3D-printed. | Bone Regeneration | ↑ release of P ions | [ |
| GeP | HA-DA/GeP@PDA Injectable Hydrogel | HA-DA and GeP@PDA aqueous solutions were mixed. Horseradish peroxidase was added as an initiator for the cross-link of the hydrogel. | Spinal Cord Injury Repair | ↓ swelling ratio but ↑ conductivity | [ |
| Boron Nitride (BN) | BN/PCL Scaffold | BN nanosheets were added to a PLC/dichloromethane solution and sprayed onto a rotatory mould. | Nerve Regeneration | ↑ mechanical properties with ↑ BN% | [ |
AC: acryloyl chloride; AMX: amoxicillin; bFGF: basic fibroblast growth factor; BG: bioglass; BMSCs: human bone marrow stromal cells; BP: Black Phosphorus; DA: dopamine; ES: electrical stimulation; GA: glutaraldehyde; GelMA: gelatin methacrylamide; GeP: germanium phosphideHA: hyaluronic acid; hBMSCs: human bone marrow stromal cells; HCHO: oxidized hyaluronic acid; hDPSCs: human dental pulp stem cells; hMSCs: human mesenchymal stem cells; HUVECs: human umbilical vein endothelial cells; MoS2: molybdenum disulphide; MSCs: mesenchymal stem cells; Nb2C: niobium carbide; NIR: near infrared; NMP: N-methylpyrrolidone; NO: nitric oxide; OSA:oxidized sodium alginate; OTES: n-octyltriethoxysilane; PAAm: polyacrylamide; PAAV: P(AAm-co-AN-CO-VIm); PAN: polyacrylonitrile; pBP: modified BP with poly(dopamine); PCL: polycaprolactone; PDA: poly(dopamine); PEA: poly(ester amide); PEG: poly(ethylene glycol); DOX: doxorubicin; PEGDA: Poly(othylene glycol) diacrylate; PEI: polyethylenimine; PGE: poly(glycerol-ethylenimine); PHA: polyhydroxyalkanoates; PLA: poly(lactic acid); PLEL: poly(d,l-lactide)-poly(ethylene glycol)-poly(d,l-lactide); PLGA: from poly(lactic-co-glycolic acid); PLLA: poly-L-lactic acid; PNIPAM: poly(N-isopropylacrylamide); PTT: photothermal therapy; PVA: poly(vinyl alcohol); PVA: polyvinyl alcohol;PVDF: poly(vinylidene) fluoride; PVP: polyvinylpyrrolidone; ROS: reactive oxygen species; SiP: silicon phosphide; TE: tissue engineering; Ti3C2(Tx): titanium carbide; TrFE: trifluoroethylene; UV: ultra-violet; VEGF: vascular endothelial growth factor.
Figure 3(a) Schematic of the BP/PLEL hydrogel gelation triggered by NIR radiation; (b) Schematic illustration of the post-surgical application of the BP/PLEL hydrogel. NIR induces gelation and promotes PTT of residual tumor while providing the site with an antibacterial platform; (c) time dependent thermographic map of the control, pristine PLEL, and BP/PLEL with NIR radiation; (d) photographs of the treatment progress throughout 16 days for control, surgery-only, and surgery + BP/PLEL with NIR hydrogel. No recurrence for the composite. Adapted from [73] © 2018 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Figure 4(a) Schematic representation of the solidification process when in contact with water and the microstructure of the implant; (b) diagram of the implant application in vivo, injection of the implant on the tumor which induces tissue hyperthermia upon NIR exposure; (c) DOX release profile under three different conditions (pH = 7.4; pH = 5.4; pH = 5.4 + NIR); (d) tumor volume under different treatments (control; PLGA/MoS2 (PM); PLGA/MoS2/DOX oleosol (PMD); PMD + NIR). Reproduced with permission from [81] © 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Figure 5Osteogenic gene expression of (a) COL-1; (b) OCN; (c) RUNX2; (d) OPN in control, bioglass scaffolds (BGS) and BG/Ti3C2 scaffolds (TBGS). * represents a p < 0.05 significance. (e) in vivo osteogenic performance of BGS and TBGS scaffolds at 24 w post-scaffold implantation. Adapted from [92] © 2019 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Figure 6Comprehensive overview of the organohydrogel performance. (a) low temperature behavior of the composite pre-EG (ethylene glycol) (a1) and post-EG (a2); (b) electrical conductivity performance of the organohydrogel at low temperatures post-EG (b1) and pre-EG (b2); (c) conducting performance of the post-EG organohydrogel cut in half (c1), after self-healing (c2), and the corresponding schemes (c3) and (c4) respectively; (d) self-healing behavior of the post-EG organohydrogel. (d1) Two pieces of the hydrogel (black—original; red—dyed with rhodamine B). (d2) Each piece was cut in half. (d3) Self-healed hydrogel with one piece from each (black and red). (d4) Stretching behavior after self-healing; (e) real-time detection of throat swallowing movements. Reproduced with permission from [88] © 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Figure 7Schematic illustration of the multifunctional therapeutic platform. (a) NO gas release triggered by NIR radiation combined with PTT destroys osteosarcoma cells while (b) slow release of NO post-PTT stimulates bone regeneration. Reproduced with permission from [99] © 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Figure 8Brief schematic illustration of the steps and challenges of incorporating 2DnMat into systems for biomedical applications. Firstly, in vitro testing to infer on the biocompatibility of the nanomaterials and their interaction with cells must be conducted. The second logical step is to proceed to in vivo testing and evaluate the biocompatibility and therapeutic effects on live models. The ability to mass produce the nanomaterials is imperative for their commercialization and large-scale use. Lastly, human testing is crucial for the evaluation of the nanomaterials therapeutic effect and its safety on humans. Created in BioRender.com.